Table 4.
Anti-metastatic effect of icariin and its derivatives.
Compound | Cell Line | Study Type | Mechanism | References |
---|---|---|---|---|
Icariin | Human lung adenocarcinoma cells (A459) | In vitro | Decreased migration and adhesion of cells | Di et al., 2015 |
Human lung cancer cells (PG) | In vitro | Decreased cell adhesive ratio to laminin substrate and reduced cell ability of invasion or migration | Mao et al., 2000 | |
Gastric carcinoma cells (BGC-823) | In vitro | Inhibition of cells migration through downregulation of cell motility-related genes Rac1 and VASP | Wang et al., 2010 | |
Icaritin | Human glioblastoma cells (U87MG) | In vitro | Downregulation of EMMPRIN via the PTEN/Akt/HIF-1α signaling pathway | Xu et al., 2015 |
Human osteosarcoma cells (SaOS2) | In vitro | Decreased cell motility, through downregulation of MMP-2 and MMP-9 expression | Wang and Wang, 2014 | |
Icariside II | Human osteosarcoma cells (HOS) | In vitro | Inhibition of the transcription of hypoxia-inducible genes involved in invasion/migration, such as uPAR, ADM, and MMP2 | Choi et al., 2008 |
Human cervical cancer cells (HeLa) and Breast cancer cells (MDA-MB-231) | In vitro | Downregulation of the expression of CXCR4, through suppression of NF-κB activation | Kim and Park, 2014 | |
Human non-small cell lung cancer cells (A549 and H1299) | In vitro and In vivo | Inhibit of TNF-α-induced migration and EMT of cancer cells in vitro and in vivo, through inhibition of Akt/NF-κB pathway | Song et al., 2016 |